CN Patent

CN101516368B — 用于施用布洛芬的方法和药物

Assigned to Horizon Therapeutics LLC · Expires 2012-10-03 · 14y expired

What this patent protects

提供向需要布洛芬治疗的对象施用布洛芬的方法，其中每天三次施用包含治疗有效量的布洛芬和治疗有效量的法莫替丁的口服剂型。

USPTO Abstract

提供向需要布洛芬治疗的对象施用布洛芬的方法，其中每天三次施用包含治疗有效量的布洛芬和治疗有效量的法莫替丁的口服剂型。

Drugs covered by this patent

Pepcid (famotidine) · Generic (originally Yamanouchi/Merck)

Patent Metadata

Patent number: CN101516368B
Jurisdiction: CN
Classification: —
Expires: 2012-10-03
Drug substance claim: No
Drug product claim: No
Assignee: Horizon Therapeutics LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.